Home › Post-COVID Conditions (Long COVID) › NCT04527315
COVID-19 Survivorship Registry
Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * have tested positive for SARS-CoV-2 and discharged from the ICU or, * have tested positive for SARS-CoV-2 and have been discharged from hospital or, * have tested positive for SARS-CoV-2 but was NOT hospitalized * ages 18 and over, and * competent and willing to sign informed consent and comply to all aspects of the protocol CONTROL Inclusion Criteria * No clinical history of COVID-19, * No active clinical symptoms indicative of possible COVID-19, * Ages 18 and over, * competent and willing to sign informed consent and comply to all aspects of the protocol Exclusion Criteria: • Participants cannot sign consent Any individual who meets any of the following criteria will be excluded from participation to the MRI or x-ray portion of the study: * Participants who are pregnant or currently trying to get pregnant * Participants unable to comply with any portion of the protocol (i.e. removing metals prior to entering the MRI scan room) or who have contraindications to MRI scanning (i.e., non-MRI-conditional pacemakers/defibrillators, pregnancy, ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants) * Persistent symptoms related to COVID-19 (in which case the patient may be re-screened later) As is done for all patients undergoing clinical MRI in our department, each patient will be screened for contraindications to MRI with a routine questionnaire prior to scanning. CONTROL Exclusion Criteria Patients with any of the following are excluded from as controls: * Pace maker * Poorly controlled diabetes * Poorly controlled Restrictive lung disease * Heart failure * Parkinson's Disease * Hypertension * Any diagnosis or history of autonomic neuropathy
About the study
COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.
What is being tested
- Questionnaires (other)
Sponsor: NYU Langone Health · Participants: 1,500 · Started: Jul 17, 2020
Contact the study team
- Ashley Witzl · Phone: 212-263-1208
- Daniel Walsh · Phone: 929-573-0079
Official record on ClinicalTrials.gov — NCT04527315
Locations in the U.S.
| New York | NYU Langone Health, New York |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.